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Abstract:
We investigated clinical factors associated with seizure clustering in patients with drug-resistant
focal epilepsy and any association between seizure clustering and outcome after surgery. We
performed a retrospective study including patients with a diagnosis of drug-resistant focal
epilepsy who underwent epilepsy surgery. Patients were prospectively registered in a database
from 1986 until 2015. Seizure cluster was defined as two or more seizures occurring within two
days. Potential risk factors for seizure clustering were assessed. To investigate any potential
association between seizure clusters and seizure outcome after surgery, time to event analysis
was used to produce a Kaplan-Meier estimate of seizure recurrence. We studied 764 patients.
Seizure clusters were reported in 23.6% of TLE patients and 16.9% of extratemporal patients (p
= 0.2). We could not identify any significant clinical factors associated with seizure clustering.
Among patients with TLE, those who had history of seizure clusters fared better after surgery (p
< 0.01). We found that seizure clusters relate to prognosis after anterior temporal lobectomy in
drug-resistant temporal lobe epilepsy. This data may provide added value for surgical
prognostication when combined with other data types. A better understanding of the
neurobiology underlying seizure clusters is needed.
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Introduction
Seizure cluster is defined as a closely grouped series of seizures 1. There is no universally
accepted definition for a cluster of seizures and published studies have used varying definitions,
including two to four seizures per < 48 hours; 3 seizures per 24 hours; or having several
convulsions within a day or two 1. Seizure clustering in patients with epilepsy is a relatively
common phenomenon with a reported prevalence ranging from 20% to 30% in some previous
studies 2, 3. Seizure clusters may impose significant risks to patients with epilepsy. They were
associated with status epilepticus, hospitalizations, and worse seizure control 3. Whether a
pattern of seizure clustering influences seizure outcome after surgery for drug-resistant seizures
in patients with focal epilepsy is not known.
It is important to investigate the clinical features associated with seizure clusters as this may help
elucidate the underlying pathophysiology. Similarly, it is desirable to know whether seizure
clusters relate to seizure outcome after surgery for drug-resistant seizures. We address these two
issues in the present investigation.

Methods
We performed a retrospective study including patients with a diagnosis of drug-resistant focal
epilepsy who underwent epilepsy surgery at Jefferson Comprehensive Epilepsy Center. Adult
and adolescent patients (above 10 years of age) were prospectively registered in a database from
1986 until 2015. The diagnosis of epilepsy was made by the epileptologists working at this
institution. Individuals with progressive neurological disease, malignant brain tumors, or
psychogenic nonepileptic seizures were excluded. Patients had a comprehensive presurgical
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evaluation including a brain MRI, scalp video-EEG monitoring, neuropsychological testing, and
other appropriate testing as clinically indicated 4. All patients had resective brain surgery.
Patients were followed for up to five years after surgery (in many patients data were missing
beyond five years of follow-up for a valid analysis). Seizure cluster was defined as two or more
seizures occurring within two days, in a habitual pattern (i.e., not only in response to medication
withdrawal or concurrent illness) that was also distinguishable from more sporadic usual
seizures. It was derived from the written histories obtained by physicians and encoded in the
database as “Yes/No”. Seizure outcome was obtained during office visits, telephone contact, and
by letter. Postsurgical outcome was classified into two groups: no recurrence of complex partial
(CPS) or secondarily generalized seizures (though auras could recur) or relapse of CPS or
secondarily generalized seizures at any time after surgery. Age, gender, race, epilepsy risk
factors [e.g., history of febrile seizures in childhood, any family history of epilepsy, etc.], age at
seizure onset, seizure type(s) and history, date of surgery, date of the first relapse (if any) and
date of the last contact with all patients were registered routinely.
Potential risk factors for seizure clustering (i.e., gender, age at surgery, duration of epilepsy,
history of tonic-clonic seizures before surgery, history of febrile seizures in childhood, family
history of epilepsy, full scale intelligence quotient (IQ), preoperative auras, and MRI findings)
were assessed comparing patients who had clusters and those who did not have clusters. We
performed Pearson Chi-square, Mann-Whitney, Kolmogorov-Smirnov, and t-test depending
upon the circumstance. To investigate any potential association between seizure clusters and
outcome after surgery, time to event analysis was used to produce a Kaplan-Meier estimate of
seizure recurrence. The Cox-Mantel test was used to compare the cumulative time-dependent
probability of occurrence of the first seizure after resective epilepsy surgery in patients with and
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without clusters. In a subanalysis, we investigated the rate of seizure freedom in the last year of
follow-up in patients with at least two years of postoperative follow-up. We classified the
patients as seizure free if they had no CPS or secondarily generalized seizures for the last year of
follow-up. P values less than 0.05 were considered as significant.
Thomas Jefferson University Institutional Review Board approved this retrospective record
review and database study. No informed consent was required, as it was a retrospective study.

Results
From 1986 until 2015, 1225 patients had epilepsy surgery; 978 patients had data on preoperative
seizure clustering available; data was missing for 247 patients. Of the 978 patients included in
this analysis, 681 (69.6%) had temporal lobe surgery and 83 (8.5%) had extratemporal surgery
and were included in this analysis; we excluded 214 patients who had corpus callosotomy, vagus
nerve stimulation, or multilobar resections with both temporal and extratemporal resection. The
proportion of temporal resections among patients with missing data was similar to the studied
group [of 247 patients with missing data, 161 (65.2%) had temporal lobe surgery (p = 0.1)].
However, relatively more patients with missing data had extratemporal surgery [39 (15.8%)
patients; p = 0.0001].
Among patients with temporal lobe epilepsy (TLE), 161 (23.6%) experienced seizure clusters
and among extratemporal epilepsy patients, 14 (16.9%) reported such an experience (p = 0.2).
Among patients with extratemporal surgery, having seizure clusters were not significantly
different between patients with frontal lobe surgery (10 out of 60) compared with those with only
parietal or occipital lobe surgery (4 out of 23); p = 1. We could not identify any significant
clinical associations for experiencing seizure clusters for the entire cohort (Table 1). Similarly,
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we could not identify any significant associations with clusters for TLE patients (all p values
were above 0.06). In patients with TLE, neither side of surgery nor presence or absence of mesial
temporal sclerosis (MTS) was associated with seizure clustering. Among patients with seizure
clusters, 41 patients had normal MRI, 66 had MTS, and 52 had other lesions (2 MRIs were
missing). Among patients with no seizure clusters, these figures were 105, 237, and 161,
respectively (17 MRIs were missing) (p = 0.3). There was no difference in the need for
intracranial EEG recordings in patients with seizure clusters (21 out of 175) versus those without
seizure clusters (87 out of 589) in the entire cohort (p = 0.3).
Next, we studied whether seizure clusters related to seizure outcome after focal resective
epilepsy surgery. Among patients with TLE, those with a history of seizure clusters fared better
after surgery than those patients who did not have clusters (p = 0.005) (Fig 1). In patients with
extratemporal epilepsy we did not observe such an association (p = 0.09).

Discussion
Seizure clusters are relatively common phenomena among patients with epilepsy, particularly
among those with drug-resistant seizures. About one fifth of our patients displayed this tendency.
While we could not identify any distinct associations between seizures clusters and particular
clinical or historical features, we observed that a history of seizure clusters was associated with a
better seizure outcome after temporal lobe surgery. One of the most important risk factors
associated with worse outcome after surgery for drug-resistant TLE is a history of preoperative
tonic-clonic seizures 5. In the current study, the prevalence of preoperative tonic-clonic seizures
was similar in patients with and without seizure clusters, so clustering appears to be an
independent prognostic factor. Hence, seizure clusters are a marker that the primary
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epileptogenic zone is more likely to be located in anterior and mesial temporal structures. More
patients with extratemporal epilepsy need to be studied before firm conclusions can be drawn
about the relationship between seizure clusters and postsurgical outcome.
Why seizures cluster is uncertain. We did not investigate the neurobiological underpinnings of
seizure clusters in this study. However, previous studies suggest that it is possible that
endogenous hormone fluctuations may lead to periods of enhanced seizure susceptibility and
other periods with greater resistance to seizure recurrence 6. Periods of enhanced susceptibility
might then have more seizures, appearing as clusters. For example, the density of dendritic
spines on hippocampal pyramidal cells is dependent on circulating estradiol and progesterone
and fluctuates naturally during the estrous cycle in female rats. Changes in dendritic spine
density during the estrous cycle are likely to have consequences for hippocampal neuronal
excitability 7. Other endogenous hormones could have similar effects. Hence, the cycling of
seizures may correspond to these structural changes.
Because, seizure clustering may impose significant risks to patients, identifying the potential
clinical associations is important. While we could not identify any associations or risk factors
associated with seizure clustering, a previous study found that head trauma and extratemporal
epilepsy were associated with seizure clusters 3. Unfortunately, our database did not contain
reliable descriptions of head trauma, so we could not assess this relationship. We could not
replicate the previously reported association of extratemporal epilepsy with seizure clusters. In
another study 8, age at epilepsy onset was lower in cluster patients than in the non-cluster
patients. We could not replicate this findings either. Given the lack of clear clinical associations,
future efforts are probably better devoted to investigating other features that might shed light on
the neurobiology of seizure clusters.
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How seizure clusters are defined 9 might influence data collection, data interpretation, and study
results, which is a potential limitation of this study. Any definition of seizure clusters is of
necessity arbitrary and clusters probably exist along a spectrum with occurrence possibly
influenced by the underlying neurobiology of seizures, medications, and other factors. We have
used a broad definition to account for the clinical picture, and recognize that a stricter definition
requiring seizures to occur over a period of a few hours might yield different results. Another
limitation of this study is the reliability of the history of seizure clusters, as it was a retrospective
study and recall bias is a potential limitation. Patients who were not seizure-free after surgery
were not systematically re-assessed to explain the reasons for postsurgical failure. These reasons
are likely to be different in people with temporal and extratemporal epilepsies, which could be a
confounder of this study, but there were unlikely to be systematic differences in extent of
resection or other features that would otherwise explain the difference. Furthermore, we did not
take into account other factors that may impact postoperative outcome 10-13. Finally, our findings
may not apply to the overall group of patients with uncontrolled seizures, as we had a special
subgroup of patients with drug-resistant focal epilepsy requiring surgery. Our findings apply to
the patients who had anterior temporal lobectomy for drug-resistant temporal lobe epilepsy and
not to other populations.
In brief, we found that seizure clusters relate to prognosis after anterior temporal lobectomy in
drug-resistant TLE. This data may provide added value for surgical prognostication when
combined with other data types 5, 10-13. A better understanding of the neurobiology underlying
seizure clusters is needed.

8

Acknowledgment
This study was not funded. We confirm that we have read the Journal’s position on issues
involved in ethical publication and affirm that this report is consistent with those guidelines.

Contributions
Ali A. Asadi-Pooya, M.D.: Study design, data collection, statistical analysis, manuscript
preparation.
Maromi Nei, M.D.: Data collection, manuscript preparation.
Ashwini Sharan: Data collection, manuscript preparation.
Michael R. Sperling, M.D.: Study design, data collection, statistical analysis, manuscript
preparation.

Disclosures
Ali A. Asadi-Pooya reports no conflicts of interest.
Maromi Nei, Research: Research: Upsher-Smith Laboratories, NINDS.
Ashwini Sharan: Consulting, Clinical Trial Site – Medtronic; SJM, Clinical Trial Site – Grant,
honorarium; ICVRX – ownership interest; ICP – ownership interest; Tiger labs – ownership
interest; Saluda Medical – Clinical Trial Site.
Michael R. Sperling: Research: Eisai, UCB Pharma, Sunovion, SK Life Sciences, Marinus,
Lundbeck, Medtronics, Accorda, Upsher-Smith, Brain Sentinel, Glaxo, Pfizer. Dr. Sperling
serves as the Editor-in-Chief of Epilepsia.

9

Reference
1. Haut SR. Seizure clustering. Epilepsy Behav 2006; 8: 50-55.
2. Haut SR, Lipton RB, LeValley AJ, et al. Identifying seizure clusters in patients with
epilepsy. Neurology 2005; 65: 1313-1315.
3. Haut SR, Shinnar S, Moshé SL. Seizure clustering: risks and outcomes. Epilepsia 2005;
46: 146-149.
4. Sperling MR, O'Connor MJ, Saykin AJ, et al. Temporal lobectomy for refractory
epilepsy. JAMA 1996; 276: 470-475.
5. Fong JS, Jehi L, Najm I, et al. Seizure outcome and its predictors after temporal lobe
epilepsy surgery in patients with normal MRI. Epilepsia 2011; 52: 1393-1401.
6. Herzog AG. Catamenial epilepsy: definition, prevalence pathophysiology and treatment.
Seizure; 17: 151-159.
7. Woolley CS, Gould E, Frankfurt M, et al. Naturally occurring fluctuation in dendritic
spine density on adult hippocampal pyramidal neurons. J Neurosci 1990; 10: 4035-4039.
8. Bauer J, Burr W. Course of chronic focal epilepsy resistant to anticonvulsant treatment.
Seizure 2001; 10: 239-246.
9. Haut SR. Seizure clusters: characteristics and treatment. Curr Opin Neurol 2015; 28: 143150.
10. Tonini C, Beghi E, Berg AT, et al. Predictors of epilepsy surgery outcome: a metaanalysis. Epilepsy Res 2004; 62: 75-87.
11. Spencer SS, Berg AT, Vickrey BG, et al; Multicenter Study of Epilepsy Surgery.
Predicting long-term seizure outcome after resective epilepsy surgery: the multicenter
study. Neurology 2005; 65: 912-918.

10

12. Asadi-Pooya AA, Nei M, Sharan A, et al. Type of preoperative aura may predict
postsurgical outcome in patients with temporal lobe epilepsy and mesial temporal
sclerosis. Epilepsy Behav 2015; 50: 98-100.
13. Asadi-Pooya AA, Nei M, Sharan A, Sperling MR. Historical risk factors associated with
seizure outcome after surgery for drug-resistant mesial temporal lobe epilepsy. World
Neurosurg 2016; 89: 78-83.

11

Figure 1. Kaplan-Meier graph showing cumulative time-dependent probability of occurrence of
the first seizure after resective epilepsy surgery in patients with temporal lobe epilepsy, with or
without preoperative seizure clusters.

Figure 1 legend. Postoperative seizure outcome was better in patients with drug-resistant
temporal lobe epilepsy who had history of preoperative seizure clusters.
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Table 1. Clinical factors in association with seizure clusters

Clinical characteristic

Patients with

Patients without

Seizure clusters

Seizure clusters

P

(N=175) *

(N=589) *

value

Sex ratio (Male / Female)

93 / 82

284 / 305

0.2

History of childhood febrile seizure

46

148

0.8

Family history of epilepsy

49

181

0.5

Aura (none/ epigastric / auditory /

40 / 28 / 2 / 11 / 12 /

197 / 85 / 17 / 37 / 24 0.08

mnemonic / affective / others / multiple)

56 / 23

/ 167 / 58

Remote history of tonic-clonic seizures

48

159

0.9

51

207

0.1

Age at epilepsy onset (years)

15 ± 11.1

15.8 ± 12.4

0.4

Disease duration (years)

18.8 ± 11.5

19.7 ± 11.7

0.3

Full scale IQ

93 ± 18

92 ± 15

0.3

(not within the past year)
Recent history of tonic-clonic seizures
(within the past year)

*Some data were missing.
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